Hints and tips:
Related Special Reports
What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon
...Previous attempts to disrupt healthcare have had mixed success. UK digital healthcare company Babylon Health, which went public at a $4bn valuation in 2021, declared bankruptcy last year....
...In the UK companies cannot advertise prescription medicines to the public but are allowed to promote them to healthcare professionals....
...London-based healthcare investor GHO Capital has this year hired advisers from JPMorgan to oversee a sales process for FairJourney Biologics, a contract research organisation that works on behalf of pharma...
...In a statement, James Sherwood, general manager for Bupa UK insurance healthcare management, said the company had “carefully considered” how to balance affordability for customers with the doctors’ demands...
...We all maintain the notion that healthcare is intended to help and heal. But the truth is, there is a difference in how men and women are supported by healthcare systems and providers....
...The number of positions offered grew by 43 per cent annually across the top 10 pharmaceutical companies alone since 2018....
...The US healthcare company said on Friday that it would pay $335 a share in cash to acquire Shockwave, which specialises in manufacturing a catheter-based treatment for patients with calcified arteries....
...The government has told the OBR to assume 1 per cent real-terms growth a year for public spending to 2028-29, but healthcare pressures are growing at least three times that fast....
...Spire Healthcare has reported double-digit profit growth as it continues to benefit from increased outsourcing by the UK’s National Health Service....
...In total, the 18 healthcare companies had assets of $7bn against liabilities of $8.3bn....
...South Korea’s government is scrambling to train more doctors in anticipation of a looming demographic crisis, as a rapidly ageing society increases demand for healthcare....
...Potential clinical uses could be in the triage of patients or where access to specialist healthcare professionals was limited....
...Companies jostling to take advantage of this shift are driving a new wave of mergers and acquisitions in the healthcare industry....
...Despite its purchasing clout as a centralised system covering all Britons, companies are often frustrated by having to deal with multiple NHS entities to get their products or solutions into England’s health...
...The company has two long-acting drugs based on cabotegravir, another integrase inhibitor, approved by regulators: Cabenuva, in combination with another molecule, for treatment of patients who have contracted...
...“If you think about a hospital bed . . . it’s basically a computer acting as a bed,” says Katell Thielemann, a cyber security expert at research company Gartner....
...However, modelling by healthcare data company Airfinity based on the trial data estimated that to prevent one heart attack, stroke or cardiovascular-related death, 67 people would need to take Wegovy for...
...He noted that “nation state actors” and “ransomware teams” were “locking in” on healthcare and other infrastructure. A cynic might argue that such warnings are not new....
...But unless the Seattle-based company acquires more healthcare groups, “its overall share of the prescription dispensing market will likely remain in the low single digits for the foreseeable future”, he...
...Grifols, Spain’s most successful global healthcare group, has been rocked by fraud allegations from a UK-based short seller that sent its share price plunging by more than 40 per cent and wiped billions...
Research forecasts global deaths from the disease will almost double in 20 years
A number of other countries have now legalised the practice
...“We are going backwards when it comes to infectious diseases in the US, and a lot of it has to do with structural racism,” says Dr Marcelo Venegas, a regional medical director at the AIDS Healthcare Foundation...
...Veritas Capital is in talks to sell a 50 per cent stake in healthcare technology company Cotiviti to private equity giant KKR, in a deal that would value the business at up to $11bn, according to three people...
International Edition